As for patients with acute promyelocytic leukemia (APL), specifically impairing the immunosuppressive axis PGD2/IL-13/NKp30 can partially decrease the numbers of ILC2s and M-MDSC to ameliorate survival (36). This evidence concerns the gene NCR3 and acute promyelocytic leukemia.